A detailed history of Barclays PLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Barclays PLC holds 129,265 shares of ATRC stock, worth $3.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
129,265
Previous 129,265 -0.0%
Holding current value
$3.97 Million
Previous $3.63 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$20.34 - $29.5 $3.56 Million - $5.16 Million
-174,803 Reduced 57.49%
129,265 $3.63 Million
Q2 2024

Aug 14, 2024

BUY
$19.86 - $29.09 $3.6 Million - $5.28 Million
181,492 Added 148.06%
304,068 $6.92 Million
Q1 2024

May 15, 2024

BUY
$28.21 - $37.78 $1.16 Million - $1.56 Million
41,281 Added 50.78%
122,576 $3.73 Million
Q4 2023

Feb 15, 2024

BUY
$32.99 - $43.25 $2.03 Million - $2.66 Million
61,580 Added 312.35%
81,295 $2.9 Million
Q3 2023

Nov 07, 2023

SELL
$41.12 - $57.73 $43,134 - $60,558
-1,049 Reduced 5.05%
19,715 $864,000
Q2 2023

Aug 03, 2023

SELL
$40.44 - $49.6 $265,326 - $325,425
-6,561 Reduced 24.01%
20,764 $1.03 Million
Q1 2023

May 04, 2023

BUY
$35.87 - $47.22 $434,206 - $571,598
12,105 Added 79.53%
27,325 $1.13 Million
Q4 2022

Feb 13, 2023

BUY
$33.48 - $47.45 $334,297 - $473,788
9,985 Added 190.74%
15,220 $676,000
Q3 2022

Nov 03, 2022

SELL
$38.25 - $52.62 $80,478 - $110,712
-2,104 Reduced 28.67%
5,235 $205,000
Q2 2022

Aug 12, 2022

SELL
$35.1 - $66.01 $117,900 - $221,727
-3,359 Reduced 31.4%
7,339 $299,000
Q1 2022

May 16, 2022

SELL
$57.43 - $71.39 $2.51 Million - $3.12 Million
-43,680 Reduced 80.33%
10,698 $703,000
Q4 2021

Feb 14, 2022

BUY
$63.4 - $87.14 $1.42 Million - $1.95 Million
22,379 Added 69.94%
54,378 $3.78 Million
Q3 2021

Nov 09, 2021

BUY
$69.28 - $84.46 $1.23 Million - $1.5 Million
17,714 Added 124.0%
31,999 $2.23 Million
Q2 2021

Aug 13, 2021

SELL
$64.13 - $80.18 $4.38 Million - $5.48 Million
-68,293 Reduced 82.7%
14,285 $1.13 Million
Q1 2021

May 13, 2021

BUY
$53.79 - $66.98 $3.46 Million - $4.31 Million
64,417 Added 354.7%
82,578 $5.41 Million
Q4 2020

Feb 11, 2021

SELL
$34.56 - $57.55 $1.15 Million - $1.91 Million
-33,245 Reduced 64.67%
18,161 $1.01 Million
Q3 2020

Nov 12, 2020

SELL
$38.36 - $46.91 $239,443 - $292,812
-6,242 Reduced 10.83%
51,406 $2.05 Million
Q2 2020

Aug 12, 2020

SELL
$31.78 - $51.19 $5.2 Million - $8.38 Million
-163,731 Reduced 73.96%
57,648 $2.59 Million
Q1 2020

May 13, 2020

BUY
$24.49 - $43.84 $4.44 Million - $7.95 Million
181,367 Added 453.28%
221,379 $7.44 Million
Q4 2019

Feb 10, 2020

BUY
$24.06 - $32.51 $481,729 - $650,915
20,022 Added 100.16%
40,012 $1.3 Million
Q3 2019

Nov 14, 2019

SELL
$23.81 - $32.52 $521,296 - $711,992
-21,894 Reduced 52.27%
19,990 $498,000
Q2 2019

Aug 14, 2019

SELL
$26.85 - $30.74 $1.07 Million - $1.22 Million
-39,785 Reduced 48.71%
41,884 $1.25 Million
Q1 2019

May 15, 2019

BUY
$26.38 - $33.34 $1.82 Million - $2.31 Million
69,172 Added 553.51%
81,669 $2.19 Million
Q4 2018

Feb 14, 2019

SELL
$26.66 - $34.85 $265,187 - $346,652
-9,947 Reduced 44.32%
12,497 $383,000
Q3 2018

Nov 14, 2018

BUY
$27.62 - $35.58 $254,214 - $327,478
9,204 Added 69.52%
22,444 $786,000
Q2 2018

Aug 14, 2018

SELL
$19.65 - $30.28 $161,090 - $248,235
-8,198 Reduced 38.24%
13,240 $357,000
Q1 2018

May 15, 2018

BUY
$15.05 - $21.03 $11,769 - $16,445
782 Added 3.79%
21,438 $440,000
Q4 2017

Feb 14, 2018

SELL
$17.69 - $23.44 $65,311 - $86,540
-3,692 Reduced 15.16%
20,656 $377,000
Q3 2017

Nov 14, 2017

BUY
$20.0 - $24.23 $486,960 - $589,952
24,348
24,348 $545,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.43B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.